Cargando…
Plant Products as Inhibitors of Coronavirus 3CL Protease
Background: The ongoing COVID-19 pandemic has created an alarming situation due to extensive loss of human lives and economy, posing enormous threat to global health security. Till date, no antiviral drug or vaccine against SARS-CoV-2 has reached the market, although a number of clinical trials are...
Autores principales: | Mandal, Anirban, Jha, Ajeet Kumar, Hazra, Banasri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985176/ https://www.ncbi.nlm.nih.gov/pubmed/33767619 http://dx.doi.org/10.3389/fphar.2021.583387 |
Ejemplares similares
-
Editorial: Plant products for antiviral therapeutics
por: Mandal, Anirban, et al.
Publicado: (2022) -
The Prospective Role of Plant Products in Radiotherapy of Cancer: A Current Overview
por: Hazra, Banasri, et al.
Publicado: (2012) -
Plant Protease Inhibitors in Therapeutics-Focus on Cancer Therapy
por: Srikanth, Sandhya, et al.
Publicado: (2016) -
A simplified cell-based assay to identify coronavirus 3CL protease inhibitors
por: Resnick, Samuel J., et al.
Publicado: (2020) -
Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors
por: Chen, Li-Rung, et al.
Publicado: (2005)